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Abstract 
 
One of the major challenges of hard tissue engineering research focuses on the development 
of scaffolds that can match the mechanical properties of the host bone and resorb at the same 
rate as the bone is repaired. The aim of this work was the synthesis and characterization of a 
resorbable phosphate glass, as well as its application for the fabrication of 3-D scaffolds for 
bone regeneration. The glass microstructure and behaviour upon heating were analyzed by X-
ray diffraction, differential scanning calorimetry and hot stage microscopy. The glass 
solubility was investigated according to relevant ISO standards using distilled water, 
simulated body fluid (SBF) and Tris-HCl as testing media. The glass underwent progressive 
dissolution over time in all three media but the formation of a hydroxyapatite-like layer was 
also observed on the samples soaked in SBF and Tris-HCl, which demonstrated the 
bioactivity of the material. The glass powder was used to fabricate 3-D macroporous bone-
like glass-ceramic scaffolds by adopting polyethylene particles as pore formers: during 
thermal treatment, the polymer additive was removed and the sintering of glass particles was 
allowed. The obtained scaffolds exhibited high porosity (87 vol.%) and compressive strength 
around 1.5 MPa. After soaking for 4 months in SBF, the scaffolds mass loss was 76 wt.% and 
the pH of the solution did not exceed the 7.55 value, thereby remaining in a physiological 
range. The produced scaffolds, being resorbable, bioactive, architecturally similar to 
trabecular bone and exhibiting interesting mechanical properties, can be proposed as 
promising candidates for bone repair applications. 
 
Keywords 
Scaffold; Phosphate glass; Resorbable material; Macroporous glass-ceramic; Bone tissue 
engineering. 
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Introduction  
 
Restoration and healing of bone defects by using bioactive materials is one of the major topics 
of research in hard tissue regenerative medicine. Silicate bioactive glasses have been the 
subject of intense interest for the last three decades due to their ability to form in vitro and in 
vivo, when exposed to physiological fluids, a surface apatite layer having the capacity to 
strongly bond to the surrounding host tissue [1-6]. A selected number of such glasses, e.g. 
45S5 Bioglass® and 13-93 glass, have received the approval for clinical use in Europe and 
USA and have shown great success in many dental and orthopaedic applications [7]. 
However, there are still some issues related to the long-term effect of released silica [8] and 
the quite slow degradation kinetics of these biomaterials, often taking many years to disappear 
from the body before being completely replaced by natural tissue [9,10]. Because of these 
limitations, the search for new materials for the repair of bone defects has continued over the 
years and has led to the development of phosphate-based glasses as valuable alternatives [11].  
Phosphate glasses, basically belonging to the P2O5–CaO–Na2O system, have unique 
dissolution properties in aqueous fluids [12]. Degradation rates can be varied from hours to 
several weeks by properly designing the glass composition and, furthermore, these glasses can 
be synthesised to include metal ions that are able to induce a specific biological effect ranging 
from enhanced osteoblast activity to antibacterial properties [13-15]. In common with silicate-
based glasses, the building block of phosphate glasses is a tetrahedral unit (PO4); however, the 
PO4 unit is quite different from the SiO4 unit [16]. In fact, phosphate glasses are formed by 
PO4 tetrahedra that can be attached to a maximum of three neighbouring units forming a 3-D 
network; the oxygen atoms that are not shared between phosphate tetrahedra allocate their two 
unpaired electrons with the P5+ ions to form a terminal double bond. The fact that phosphate 
anions contain at least one terminal oxygen limits the connectivity of phosphate-based glasses 
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in comparison to their silicate-based counterparts. Pure vitreous silica (SiO2) is thermally and 
chemically stable; the addition of modifying oxides, such as Na2O, K2O, MgO and CaO, 
which are not part of the glass network and disrupt it, resulting in terminal Si–O bonds, 
produces less stable glasses. On the contrary, pure vitreous phosphorus pentoxide (P2O5) is 
chemically unstable with regard to hydrolysis of the P–O–P bonding by atmospheric 
moisture; in this case, the addition of metal oxides improves its stability because P–O–M+ 
bonds (where M = alkali or alkali earths cation) are generally more stable towards 
atmospheric hydrolysis. With respect to silicate glasses, phosphate-based systems can be 
prepared at relatively low melting temperatures and can easily be drawn into fibres; thanks to 
this feature, use of phosphate glasses in soft tissue engineering for production of conduits for 
peripheral nerve regeneration [17,18] or muscle tissue regeneration [19] has been proposed. 
Compared to silicate glasses, phosphate glasses have poor chemical durability and low 
mechanical properties; however, their application in the context of bone tissue engineering 
offers interesting perspectives thanks to their compositional versatility. By purposely tailoring 
the glass composition, it is possible to develop glasses having dissolution rate compatible with 
the kinetics of new bone formation; furthermore, phosphate glasses can act as carriers for the 
controlled release of oligo-elements exerting specific therapeutic actions in vivo [20]. 
In the context of tissue engineering, biomedical glasses have been also used for the fabrication 
of 3-D porous scaffolds. An ideal scaffold for bone grafting should fulfil a complex set of 
requirements, including high porosity (above 50 vol.%, i.e. comparable to that of cancellous 
bone), macropores size exceeding 100 µm, highly interconnected 3-D porous network, 
mechanical strength matching that of host bone, bioresorbability rate similar to that of bone 
regeneration and biocompatibility of the degradation products [1,3,21-24]. Different methods 
have been proposed to produce bioceramic scaffolds, including starch consolidation [25,26], 
H2O2 foaming [27], gel-casting [28,29], sponge replication [30-35], sponge replication 
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combined with gel-casting [36] and polymer particles burning-out [37-40]. The above-
mentioned methods were widely applied over the last decade to process fully-crystalline 
ceramics, such as hydroxyapatite (HA) or β-tricalcium phosphate (β-TCP), or silicate glasses; 
however, to the best of the authors’ knowledge few attempts to process phosphate glasses in 
porous form have been reported in the literature. In 2004, Navarro et al. [41] described the 
preparation of P2O5-CaO-Na2O-TiO2 scaffolds by H2O2 foaming; two years later, Park et al. 
[42] illustrated the synthesis of CaO-CaF2-P2O5-MgO-ZnO scaffolds by using the sponge 
replication technique. More recently, in a couple of articles Vitale-Brovarone et al. [43,44] 
proposed the fabrication of P2O5-SiO2-CaO-MgO-Na2O-K2O scaffolds by the foam replica 
method; phosphate glass/gelatin composite scaffolds with bilayered structure have been also 
proposed for ostechondral regeneration [45].  
In the present work, phosphate glass-ceramic scaffolds were fabricated by the burning-out 
method using polyethylene (PE) particles as pore forming agent, in order to obtain porous 
bodies with mechanical strength comparable to that of cancellous bone. PE burning-out 
method is applied here for the first time to fabricate phosphate glass-derived scaffolds. An 
accurate investigation of the starting glass was also reported, especially as far as its sintering 
and crystallization upon heating and its solubility in physiological media are concerned; these 
analyses were not systematically performed previously and the knowledge of such 
characteristics is essential for a rational development of glass-derived scaffolds. 
Microstructural and morphological characterizations of the scaffolds were carried out by X-
ray diffraction and scanning electron microscopy, respectively; scaffolds porosity, solubility 
in different media and mechanical properties were also determined.  
 
Materials and methods 
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Starting glass 
 
Glass synthesis. The starting glass, referred to as ICEL2, is a 6-oxide glass having the 
following molar composition: 45% P2O5, 3% SiO2, 26% CaO, 7% MgO, 15% Na2O and 4% 
K2O. ICEL2 was prepared by using the following high-purity raw products: Na3PO4·12H2O, 
Ca3(PO4)2, SiO2, (NH4)2HPO4, Mg3(PO4)2·8H2O and K2HPO4 (Sigma-Aldrich). The reagents 
were ground in a ball mill for 1 h to ensure good mixing and then melted in a platinum 
crucible at 1200 °C for 30 minutes in air (heating rate: 10 °C min-1). The melt was poured into 
rectangular shape brass moulds at room temperature to obtain glass bars. A part of the ICEL2 
glass bars was annealed at 375 °C for 12 h, whereas the residual bars was ground in powders. 
Annealing reduced the internal stresses induced by rapid cooling, thereby avoiding the 
formation of cracks during slicing the glass bars. The annealed bars were cut into small slices 
(around 10 mm × 10 mm × 1.2 mm) by using a cutting machine (Struers Secotom-10) with a 
diamond cut-off wheel. The glass slices were further used for the solubility tests. The non-
annealed bars were ground for 1 h in a ball mill and the obtained powder was then sieved 
below 106 µm by using stainless steel sieves (Giuliani Corp., Italy). The so-obtained ICEL2 
glass powder was finally used to prepare the porous scaffolds, as described in the section 2.2).  
 
Microstructural and thermal analysis. X-ray diffraction (XRD) pattern of ICEL2 glass powder 
was registered by a Philips X`Pert diffractometer with Cu Kα radiation for a 2θ range within 
10-70° (Bragg-Brentano camera geometry; working conditions: 40 kV and 30 mA; incident 
wavelength: 0.15405 nm).  
 The characteristic temperature of ICEL2, i.e. glass transition temperature (Tg), onset 
crystallization temperature (Tx), peak crystallization temperature (Tc) and melting temperature 
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(Tm), were determined by a Perkin Elmer DSC7 differential scanning calorimeter, in argon 
atmosphere, using a heating rate of 10 ° C min-1.  
The sintering process of ICEL2 was directly observed by hot stage microscopy (HSM), that 
allows the quantification of the sintering parameters by measuring the variation of the samples 
dimensions during the heating process. The behaviour of the samples during heating was 
analyzed by a Leitz-Wetzlar heating stage optical microscope in air atmosphere, using a 
heating rate of 10 °C min-1. The samples were obtained by pressing ICEL2 powder into small 
cubes (3-mm edge length) using a small stainless steel die. The specimens were observed by a 
video-camera and the photos of their silhouettes were registered up to 700 °C. The samples 
shrinkage was calculated at specific temperatures from the variation of the samples area, 
using the following equation: 
100
A
A(%) shrinkage
0
T ×=
                                      (1) 
wherein A0 (mm2) was the initial area of the specimen silhouette at room temperature and AT 
(mm2) was the area of the specimen silhouette at the temperature T. 
 
Solubility tests. The glass solubility was tested at 37 °C on glass slices by using three 
different solutions, i.e. distilled water, simulated body fluid (SBF) and Tris-HCl as 
recommended by ISO standard [46], for a total soaking time of 4 months. SBF was prepared 
by using Kokubo’s protocol [47]. Tris-HCl is a solution obtained by dissolving tris-
hydroxymethylamino methane (NH2C(CH2OH)3) in distilled water, followed by regulating 
the pH at 7.4 by using 1 M HCl. ICEL2 slices were immersed in 15 ml of each solution at 37 
°C in PE bottles. The solutions were refreshed twice a week and the pH was measured before 
refreshing. The samples were removed from each solution after different soaking time and let 
to dry in air. The weight of the samples was measured before and after soaking; the weight 
loss was calculated with the following equation: 
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100
W
W-W(%) lossweight 
0
t0 ×=
                                  (2) 
wherein W0 (g) is the initial weight of the specimen and Wt (g) is the weight of the specimen 
at the immersion time t.  
The tests were performed on triplicate samples, and the presented weight losses are an 
average of the acquired data. The weight loss per unit surface was calculating by dividing the 
weight loss by the initial surface area of the specimens. Some selected samples were 
chromium-coated and investigated by scanning electron microscopy (SEM; Philips 525M, 
accelerating voltage 15 kV) and energy dispersive spectroscopy (EDS; Philips Edax 9100) for 
compositional analysis. 
 
Glass-derived scaffolds 
 
 Scaffolds fabrication. ICEL2-based scaffolds were fabricated using the PE burning-out 
method. This method involved the preparation of green bodies by mixing PE particles 
(Wrigley Fibres Co. Ltd, UK) and ICEL2 glass powders, as reported elsewhere by the authors 
for silicate glass scaffolds [37-39]. Briefly, a homogeneous blend of PE particles (50 vol.%; 
particle size between 100-300 µm) and ICEL2 glass powder (particles size below 106 µm) 
was obtained by using a tube roller (mixing time: 1 h). The mixture was then pressed into a 
cylindrical stainless steel mould (diameter: 30 mm) by using a uniaxial press (applied stress: 
120 MPa). The obtained green body discs were thermally treated at 550 °C for 3 h in air 
atmosphere (heating rate: 10 °C min-1) in order to have the complete removal of the organic 
phase and the sintering of the inorganic particles. The sintering temperature was properly 
selected on the basis of the HSM data.  
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Microstructural and morphological characterization. ICEL2-derived scaffolds were 
crushed in fine powders and analyzed by XRD (according the operating conditions reported in 
the section 2.1.2) to investigate the development of crystalline phases; X’Pert HighScore 
program and PCPDFWIN database (JCPDS - International Centre for Diffraction Data) were 
used for identification. 
The scaffolds 3-D architecture was analysed by SEM according to the experimental set-up 
described in the section 2.1.3.  
 
Porosity assessment. The total porosity of the scaffolds was calculated with the following 
equation:  
1001(%) P
g
s ×







−=
ρ
ρ
                                          (3) 
wherein ρs (g cm-3) is the scaffold density (measured from mass-volume evaluations) and ρg 
(g cm-3) is the ICEL2 bulk glass density (measured by exploiting the Archimedes’s principle, 
using a density kit attached to an analytical balance). The porosity was expressed as mean 
value ± standard deviation calculated on 10 samples. 
Quantitative assessment of pores size distribution was carried out by image analysis (Qwin 
Leica software) on low-magnification SEM pictures of polished cross-sections of the 
scaffolds (three images were considered for each measurement). This program enhances the 
difference in contrast between the “empty space” (pores) and “filled space” (struts) and 
calculates the number of pores within a specific size range, as well as their surface area. The 
pores, identified by black colour, were approximated as spherical by the software; hence, the 
equivalent pore radius R (µm) is calculated from the formula: 
pi/R pA=                                                 (4) 
where Ap (µm2) is the pore area measured by the program. 
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 The degree of interconnectivity was estimated from a qualitative viewpoint by observing the 
absorption of a red coloured fluid by the scaffolds due to capillary forces. For this purpose, a 
mix composed by 30 vol.% of calf serum and distilled water was prepared as a testing 
medium; few drops of red ink were added to the serum solution for better visualization. The 
bottom part of the scaffold was put in contact with this red serum solution and the time 
required for the penetration of the liquid inside the scaffold and up to its top was registered.  
 
Mechanical tests. The strength of the scaffolds was evaluated through crushing tests on 10 
mm × 10 mm × 10 mm cubic samples (MTS System Corp. apparatus, 5-kN cell load, cross-
head speed set at 1 mm min-1). The compressive failure stress σc (MPa) was calculated as 
R
M
c A
L
=σ ,                                                              (5) 
being LM (N) the maximum load registered during the test and AR (mm2) the resistant section 
area. 
The energy per unit volume VE  (J mm-3) absorbed by the scaffold till the breaking off is 
reached was defined as the energy necessary to deform a specimen from the unloaded 
condition to the failure strain εf, and was calculated as the area under the stress-strain curve up 
to εf [48]:  
εεσ
ε
∫=
f
dEV
0
)( ,                                                            (6) 
wherein the strain ε is the integration variable; the initial condition is 0)0( ==εσ  and the 
final state is cf σεεσ == )(  (calculated from Eq.(5)). 
The above-mentioned mechanical parameters were expressed as mean value ± standard 
deviation calculated on five samples.   
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In vitro tests. The scaffolds solubility was assessed only in SBF, being this solution 
recognized by the scientific community as the “gold standard” medium for assessment of 
biomaterials behaviour in vitro. ICEL2-based scaffolds were soaked in 15 ml of SBF at 37 °C 
in PE bottles for a time span of 4 months. The solution was refreshed twice a week and the pH 
was registered before refreshing. The weight was measured before and after different soaking 
time and the weight loss was calculated with Eq.(2). The tests were performed on triplicate 
samples, and the presented weight losses are an average of the acquired data. At the end of the 
experiment, some samples were gently washed with distilled water, dried at room 
temperature, chromium-coated and investigated by SEM and EDS (experimental set-up 
described in the section 2.1.3.).  
 
Results and discussion  
 
Parent phosphate glass 
 
Considerations on the design of glass composition. ICEL2 was developed by modifying the 
chemical composition of an experimental silicate glass named CEL2 and proposed by the 
authors for biomedical applications since the mid 2000s [31,33,37,49,50]. The oxide-based 
formulations of ICEL2 and CEL2 can be considered “specular” [43], as the molar amounts of 
SiO2 and P2O5 in the ICEL2 composition were inverted in comparison to those of CEL2; the 
so-obtained phosphate glass is characterized by small silica content and no variation of the 
amounts of modifying oxides, as well as of the former/modifying oxides molar ratio, with 
respect to CEL2 composition.  
The integration of modifying oxides into the phosphate glass composition has a significant 
effect on the glass structure and its dissolution rate, contributing to improve its resistance to 
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hydrolysis [11,16]. Ca and Mg ions also play an important role from a biological standpoint, 
as they are involved in bone metabolism and are known to stimulate osteoblasts proliferation 
and new bone growth [51]. 
Concerning the effect of SiO2, i.e. the co-former oxide of ICEL2 together with P2O5, it was 
demonstrated that it breaks the phosphate glass network, which results in an increased 
degradation rate [52]. Incorporation of silica in ICEL2 formulation is essential considering the 
specific applications of the glass in regenerative medicine: in fact, it has been reported that 
SiO2 increases the Ca nodule formation in osteoblasts cultures and seems to stimulate the 
osteoblasts differentiation [29,53]. More generally, it has been demonstrated that the 
dissolution products of bioactive glasses exert a genetic control over the osteoblasts cycle, and 
silicon was found to play a key role in bone mineralization and gene activation towards a path  
of osteogenesis and self-repair [51,53].  
 
Sintering and crystallization of the glass. The XRD pattern of as-poured ICEL2 is shown in 
Fig. 1a; the presence of a broad halo indicates a completely amorphous phase. The amorphous 
halo, which is characteristic of glass samples, can be observed for 2θ between 20-40°. 
DSC curve of ICEL2 glass powder is reported in Fig. 2. The glass transition temperature 
occurs at Tg = 410 °C. The graphic presents a large exothermic peak whose maximum is 
around Tc = 600 °C and two small endothermic peaks between 650-700 °C. The exothermic 
peak corresponds to crystallization phenomena (the crystallization onset was detected at Tx = 
550 °C), while the two endothermic peaks represent a double melting process (i.e., melting of 
two crystalline phases). The broadness of the exothermic peak suggests the crystallization of 
two phases, as observed from XRD pattern in Fig. 1b (described in more detail in the section 
3.2.1) and in accordance with the detection of two melting temperatures by DSC.  
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Glass stability against crystallization upon heating can be evaluated, from a quantitative 
viewpoint, by considering the following difference estimated from DSC plot (Fig. 2): 
δ = Tx – Tg                                                             (7) 
 
This parameter indicates the tendency towards crystallization of the glass composition, as a 
greater difference reveals a lower tendency to crystallization, i.e. a greater stability of the 
material in its vitreous state upon heating. In the case of ICEL2 we had δ = 140 °C.     
Hruby [54] proposed another parameter, KH, defined as 
xm
gx
H TT
TT
K
−
−
=                                                           (8) 
that can be used to measure glass stability. According to Hruby, the larger KH of a certain 
glass, the greater its stability against crystallization upon heating. In the case of ICEL2 we 
assessed KH = 1.4. 
ICEL2 glass shrinkage as a function of increasing temperature is shown in Fig. 3. The sample 
exhibited no geometrical variation up to TFS = 350 °C (first shrinkage) and then it began to 
contract; the shrinkage reached its maximum (60 %) at TMS = 470 °C (maximum shrinkage). 
For temperatures higher than TEP = 550 °C (end of the densification plateau) the sample 
volume increased due to crystallization phenomena, in good agreement with DSC results. The 
maximum increase of the volume was reached at 620 °C; afterwards the material, that was 
converted into a glass-ceramic, started to melt.  
Lara et al. [55] recently introduced a new parameter, Sc (sinterability), that estimates the 
competition between glass sintering and crystallization of glass powders during heating:  
Sc = Tx – TMS                                                       (9)  
It represents a measure of the ability of sintering versus crystallization: the greater Sc, the 
more independent are the kinetics of these two processes. Specifically, Sc can be interpreted 
according to these general criteria: if Sc < 0, only partial densification is achieved before 
  
15
crystallization begins; otherwise, if Sc ≥ 0, full densification occurs prior to crystallization. 
Therefore, higher Sc are related to higher final densities, which indicated a better sintering 
behaviour involving a higher densification of the final sample. In the case of ICEL2, we 
obtained Sc = 80 °C. 
Table 1 gives a comparison among the thermal parameters calculated for ICEL2 in the present 
work and those available in the literature for other biomedical glasses. To the best of the 
authors’ knowledge, unfortunately, no comparison among ICEL2 and other phosphate-based 
glasses is directly possible (CEL2 [34], 45S5 Bioglass® [56] and the glasses investigated by 
Kansal et al. [57] are all silicate materials). The parameters related to glass stability against 
crystallization and sinterability of ICEL2 are superior than those of its specular counterpart 
CEL2, as well as of 45S5 Bioglass®.  
Before discussing about ICEL2-derived scaffolds, few considerations about the selection of 
the optimal sintering temperature deserve to be reported here. As a general guideline, data 
from thermal analyses are helpful to biomaterials researchers for choosing the most 
appropriate sintering temperature to produce glass-derived scaffolds; this selection is 
commonly carried out with the aim of obtaining a good compromise between densification, 
required to strengthen the struts of the final porous body, and porosity, which is recommended 
to be above 50 vol.% in order to promote cell colonization, implant vascularisation and bone 
in-growth in vivo [24,29]. However, it is worth underlining that the sintering process of 
scaffolds obtained by PE burning-out, like those fabricated in this work, is quite different 
from the sintering of compact bodies of glass powder, like those used for HSM. In fact, during 
thermal treatment of the glass/PE green bodies we assist not only to 
densification/crystallization of glass particles, but also to the burning-out of the polymeric 
additive, which may introduce additional shrinkage or expansion (due to gas development) of 
the structure. Furthermore, PE particles leave large macro-voids in the 3-D scaffold structure 
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to be consolidated during sintering, whereas the pores detectable in compact bodies of glass 
powders are attributable to small intra-particulate voids. From a theoretical viewpoint, HSM 
of a glass/PE compact body would maybe give more accurate information to select the 
optimal sintering temperature for scaffolding, but for purpose of simplicity such an approach 
has been never followed neither in the literature nor in the present work. In the authors’ 
opinion this choice is fully acceptable, also considering that, although HSM can certainly 
provide a range of potentially suitable sintering temperatures, the “optimal” sintering 
temperature can be found only through a fine evaluation involving the production, thermal 
treatment and morphological investigation of some test samples; this issue was already 
discussed elsewhere by the authors with reference to sponge-replicated scaffolds [34].  
As a general criterion, the sintering temperature should be chosen in the range between the 
maximum densification and the onset of crystallization; therefore, the sintering temperatures 
to be selected for ICEL2 are in the 470-550 °C range, wherein the best densification can be 
obtained. The optimal thermal treatment for ICEL2 scaffold fabrication was selected at TEP = 
Tx = 550 °C for 3 h in air atmosphere. For temperatures lower than 550 °C, the organic phase 
was not completely burnt-out and the scaffold structure was only partial sintered (the sintering 
took place in solid state), which ensued in high brittleness and weak mechanical properties. 
Increasing the temperature, the glass viscosity decreased and at 550 °C viscous flow sintering 
occurred, which allowed the glass particles to be bound together into a structure with a higher 
density. Adopting thermal treatments above 550 °C, the scaffold structure partially collapsed 
due to a high degree of melting. 
 
In vitro tests. Digital camera images of ICEL2 glass slices before and after soaking for 4 
months in three different media (distilled water, Tris-HCl and SBF) are shown in Fig. 4. As 
can be noticed, the samples immersed in Tris-HCl (Fig. 4b) and SBF (Fig. 4c) had a white 
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layer on top of them after immersion. This layer was identified by EDS analysis as a calcium 
phosphate (CaP), which precipitated during the soaking period. In fact, as previously reported 
by other authors [58], when the dissolution time raises, the release of phosphates in the 
solution increases and, in media such as SBF, the saturation occurs rapidly thereby leading to 
the precipitation of a HA-like phase. Due to the presence of a newly formed CaP layer, the 
weight losses that occurred in these two solutions (Tris-HCl and SBF) were underestimated. 
On the contrary, as can be observed in Fig. 4a, no precipitation of new phases occurred on the 
sample soaked in distilled water, and thus its area and thickness were much smaller than those 
of the samples maintained in Tris-HCl and SBF. The precipitation of this CaP layer, similar to 
the apatite phase present in the natural bone [59,60], indicates a bioactive behaviour of ICEL2 
glass.  
Fig. 5 reports the weight loss in the three different media up to 4 months of soaking. As can 
be noticed, the glass dissolution increased over time in all media and had a significantly 
higher rate for distilled water. For instance, the weight loss after 4 months of immersion in 
distilled water reached almost 76 wt.%, while the samples soaked in Tris-HCl and SBF lost 
only 21 wt.% and 29 wt.%, respectively, of their initial own weight. This variation among the 
groups can be explained by considering the precipitation of the CaP layer on the samples 
surface during the immersion in SBF and Tris-HCl, as its presence partially balanced the 
weight loss due to stoichiometric dissolution of polyphosphate chains. Furthermore, the 
presence of this CaP layer slowed down the hydrolysis of the phosphate glass as its direct 
contact with water molecules is partially hindered by the precipitated layer acting as a 
“protecting skin”. However, the dissolution rate was higher than the CaP precipitation rate, 
and therefore a weight loss was registered also for the samples soaked in Tris-HCl and in 
SBF. 
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The average weight loss per unit surface of ICEL2 glass samples after different time of 
immersion in distilled water is presented in Fig. 6 (continuous line). The coefficient of 
determination R2 = 0.9981 of the linear fitting curve y = 1.7114x (dashed line) indicates a very 
good fitting (correlation coefficient R = 0.99905). The linear trend suggests a homogeneous 
(congruent) dissolution of the glass due to surface erosion; this is consistent with current 
knowledge on phosphate glasses that are considered erosion-controlled systems, in 
accordance with a kinetic limited by the dissolution of the hydrated polyphosphate chains 
[61]. According to the fitting curve equation, the ICEL2 dissolution rate in water was constant 
and equal to about 1.7 mg cm-2 day-1. The dissolution remained linear with time as the test 
solution was periodically replenished; in this condition, the ionic strength of the solution was 
kept nearly constant, otherwise an increase of the ionic strength would have caused a decrease 
of the dissolution rate [61].  
An approximately linear trend of weight loss with time was also observed for the Tris-HCl 
group; in this medium, the dissolution rate was less than the one observed in distilled water, 
due to the precipitation of the CaP layer, as previously discussed. In the case of SBF, the 
situation was more complex: the dissolution rate was nearly linear over the first 14 days of 
immersion, then decreased tending to zero and after 1 month increased again with a linear 
trend (also in this case the dissolution rate was lower than that registered in distilled water). It 
is possible to hypothesize that, after this time span, the CaP layer (or even only some regions 
of it) reached a critical thickness, thereby tending to detach from the substrate glass; 
accordingly, the removal of this “physical barrier” would involve an acceleration of the 
dissolution rate. The chelating ability of increasing concentration of polyphosphate ions in 
solution towards divalent cations in the hydrated layer of the glass might also have enhanced 
the dissolution process, as suggested by Gao et al. [59].     
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Phosphate glass-derived scaffolds 
 
Microstructure, architecture and morphology. A digital image of a pressed glass/PE disc 
(green body) before sintering is shown in Fig. 7a. During the thermal treatment the glass 
crystallized and, therefore, the obtained scaffolds had a glass-ceramic microstructure (Fig. 
1b). Two crystalline phases, i.e. Na2Mg(PO4)3 and Ca2P2O7, were identified from XRD 
analysis, in good agreement with the DSC curve (Fig. 2) showing two melting peaks that 
corresponded to the above-mentioned crystalline phases. Phase identification is also 
consistent with the results reported elsewhere by the authors [62]. It should be taken into 
account that the sintered ICEL2 constituting the macroporous scaffolds is actually a glass-
ceramic material; however, for purpose of simplicity the expression “ICEL2 scaffold” will be 
adopted hereafter, without further specifying its glass-ceramic nature. 
During the heat treatment, the ICEL2 glass particles sintered and the PE particles burnt-out 
producing a grey smoke. The removal of the gaseous products occurred in the same time with 
the glass softening and thus the green body discs remarkably swelled during the thermal 
treatment. The obtained scaffolds had the height up to 3 times larger than that of the starting 
green bodies and looked like a “cake” (Fig. 7b). The grey colour of the sintered scaffolds was 
due to the presence of some carbon residuals (not completely eliminated owing to the 
relatively low sintering temperature) entrapped in the structure during the passage of the 
smoke through the sample; compositional analysis by EDS revealed that carbon traces are 
negligible. The gases produced during PE pyrolysis flowed up from the bottom to the top of 
the samples, thereby contributing to create a macroporous structure with a 3-D interconnected 
network of pores that can be easily observed by naked eye (Fig. 7c). The scaffolds 
microstructure is shown in Fig. 7d. The SEM image reveals the presence of both macropores 
(size in the 100-400 µm range) and micropores (< 20 µm) exhibiting a good degree of 
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interconnectivity. In general, the pores wall structure is very well sintered. At 550 °C, the 
surface of the glass particles was in a viscous state; this viscous fluid produced at the interface 
between the glass particles created a better contact between the adjacent glass particles, 
thereby driving to the formation of a highly sintered structure (Fig. 7d).  
The scaffold porosity calculated by mass-volume measurements was 87 ± 3 vol.%. Percentage 
porosity is a key parameter to preliminarily estimate the suitability of a given scaffold for 
tissue engineering application; for instance, a total porosity above 50 vol.% is generally 
recommended for bone tissue scaffolds [24]. However, other parameters such as pores size, 
distribution and interconnectivity deserve careful consideration in the process of scaffold 
design and development. 
The capillarity test performed on a ICEL2 scaffold to qualitatively investigate the 
interconnectivity of its pores is shown in Fig. 8. The scaffolds could absorb the red serum in a 
couple of seconds; the fast uptake was due to the presence of a network of highly 
interconnected micropores and to their capillarity effect on the fluid (Figs. 8a-f). Scaffolds 
before and after the capillarity test are displayed in Figs. 8g,h: qualitative observations of the 
scaffold surface and cross-section showed a uniform red colour, which further confirmed the 
existence of a porous network with a high degree of interconnectivity. 
The features of the pore network will influence permeability, which will affect how body 
fluids penetrate into the scaffold as well as the rate of cell migration and vascularised bone in-
growth. In the present work, the intrinsic permeability k (m2) in Darcy’s flow region was 
estimated by using the following equation [63]:  
2
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wherein D (m) is the mean pore diameter and ξ is the effective porosity.  
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The effective porosity ξ, whose values are in the 0-1 range, is defined as the fractional volume 
of pore space that permits the fluid flow; it is different from the absolute porosity P (assessed 
by Eq.(3)), which is defined as the percentage of total void space with respect to the bulk 
volume regardless of the interconnection of the pore voids. The mean pore diameter D refers 
to the effective porosity ξ and was estimated by image analysis (Qwin Leica software) 
excluding from the calculation the pores with size below 10 µm, as they constituted only a 
sort of surface roughness on the scaffold struts; several cross-sectional low-magnification 
SEM images of ICEL2 scaffolds were analyzed for this purpose. Likewise, the parameter ξ 
was estimated subtracting the contribution of the small pores below 10 µm from the total 
pores content P. The estimates of D and ξ were ∼40 µm and ∼0.84, respectively. It cannot be 
ignored that such evaluations represent only an approximate assessment of the real values of 
the parameters since image analysis provides results that refer to a 2-D geometry (cross-
sectional pictures of the samples were processed), whereas a more realistic analysis of 
scaffold porosity should be carried out in 3-D. However, this simplified approach is generally 
considered acceptable by researchers and has been followed in the literature for preliminary 
investigation of porous glass biomaterials [33,34,44] as it is able to lead to quite reliable 
results [64]. Therefore, by using Eq.(10) the estimate of ICEL2 scaffolds permeability was k = 
2.47·10-10 m2. It is interesting to compare the value of permeability assessed for the present 
ICEL2 scaffolds with data available in the literature. In the case of bone, for instance, values 
between k = 2.0·10-9 and k = 9.5·10-9 m2 have been reported for cancellous bovine bone with 
ξ in the 80-90 vol.% range [65]. Values of k = 7.22·10-9 and k = 5.13·10-9 m2 have been found 
for human trabecular bone of the vertebral body and proximal femur, respectively, although 
significant variation from these values may be obtained dependent of the harvest site and local 
porosity [66]. Shimko et al. [67] found values of intrinsic permeability in the range k = 
5.2·10-10-6.2·10-10 m2 for tantalum scaffold having porosity within 90-95 vol.%. Li et al. [68] 
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established k = 2.13·10-10 m2 for calcium phosphate scaffolds, and more recently Ochoa et al. 
[69] reported k = 1.96·10-9 m2 for 45S5 Bioglass® foams with porosity above 90 vol.%. The 
estimate of permeability for ICEL2 scaffolds is comparable to the range of the reported 
experimental data for trabecular bone and bone tissue engineering scaffolds, confirming that 
the produced samples are interesting structures for bone repair.  
At present, studies reporting the evaluation of biomedical scaffolds permeability are quite rare 
in the literature, probably due to the complexity of the approaches to be followed for its 
evaluation. Experimental measurements of permeability in biomaterials with 3-D 
interconnected porous networks can be very difficult if the considered materials are highly 
brittle, like the majority of biomedical glass and ceramic scaffolds; furthermore, the 
development of a purposely-dedicated measurement system is needed [63,69]. An alternative 
method for measuring the permeability of sol-gel glass scaffolds was proposed by Jones et al. 
[70,71] and involved the use of 3-D geometry of the porous sample obtained via micro-
computed tomography (micro-CT) in a microscale flow simulation. The flow within porous 
medium obeys Stokes equations at the local scale; hence, the permeability can be calculated 
using the geometry and by numerically solving a Stokes-like problem obtained by volume 
averaging. This technique has a great potential as it allows non-destructive observations of 
areas of dominant flow within an individual scaffold; however, the need for a micro-CT 
equipment implies high cost for the analysis and the development of a purposely-dedicated 
software may be necessary; furthermore, the analysis can be dramatically time-consuming. 
More accurate measurements of ICEL2 scaffolds permeability are planned in the future to 
refine the present estimate. 
 
Mechanical properties. A typical compressive stress-strain curve of ICEL2 scaffold is shown 
in Fig. 9. The failure compressive strength was 1.5 ± 0.5 MPa; in the light of the suggestions 
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from the literature, this value can be considered acceptable for applications in the context of 
bone tissue engineering, being close to the lower threshold of the strength range of trabecular 
bone (2-12 MPa [72]). The achievement of such a compressive strength is a significant result 
in the light of the high porosity of these scaffolds (about 87 vol.%): their porosity/resistance 
ratio is actually comparable to that of some natural materials (e.g. cancellous bone, but also 
coniferous tree wood) or artificial structures for advanced applications (e.g. aluminium 
honeycomb).  
As far as the authors are aware, the mechanical strength of the ICEL2 scaffolds produced in 
this work is superior to that of biomedical glass scaffolds with analogous porosity reported in 
the literature. For instance, it is interesting to notice that 45S5 Bioglass® scaffolds, having a 
pore content of 85-90 vol.% and often considered as a standard reference to which compare 
new macroporous bioglasses, exhibit a compressive strength around 0.3-0.4 MPa [30], which 
is significantly lower than that of the ICEL2 scaffolds presented in this work. A compressive 
strength of 1.5 MPa was achieved for highly porous (85 vol.%) 45S5 Bioglass® foams after 
toughening by means of a polymeric coating [73].  
The present ICEL2 scaffolds produced by PE burning-out are also stronger than those made 
of the same material but fabricated by the authors elsewhere through sponge replication 
method (∼0.4 MPa [43,44]). This trend can be observed for all existing biomedical glass 
scaffolds that were produced by these two different methods, as shown in Table 2. From a 
general viewpoint, in the scaffolds produced by PE burning-out the pores are separated by 
thick struts without the presence of an actual bone-like trabecular structure with very thin 
struts characterizing the samples manufactured through replication method: therefore, the 
higher mechanical strength is negatively counterbalanced by an architecture somewhat 
different than the one featuring cancellous bone and by a lower degree of pore 
interconnectivity.  
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The ICEL2 scaffolds investigated in this work, although being produced by PE burning-out, 
nevertheless exhibit a bone-like morphology with a high degree of pores interconnectivity; 
such characteristics were reasonably due to the simultaneous glass particles 
softening/sintering and PE removal during the thermal treatment, which induced the 
“foaming” of the structure (Fig. 7b). This phenomenon does not occur for silicate glass 
scaffolds (Table 2) as they need a higher temperature of sintering (normally above 900 °C): 
therefore, first PE particles burn-out and then glass particles sintering occurs (the two 
processes are “decoupled”), which eventually ensues in a shrinkage of the scaffold.    
By decreasing the pores content (porosity of 50 vol.% minimum is recommended for bone 
scaffolds [24]), which can be performed by introducing a lower amount of PE particles in the 
starting glass/PE mix, it would be possible to further increment the mechanical strength of the 
ICEL2 scaffolds, whose use could be maybe suggested also for load-bearing applications. 
In spite of the high pore content, the scaffolds can be easily cut with a blade without 
crumbling (Fig. 7c); this supports their use for clinical applications, as surgeons would be able 
to safely handle and to carve them into the desired shape without breaking. 
The energy absorption capacity was calculated from the area under the stress-strain curve; 
specifically, the energy absorbed by the scaffold up to its breaking off was EV ∼ 150 kJ m-3. 
This value is about one order of magnitude higher than that assessed for ICEL2 scaffolds 
produced by sponge replication [44] and might be further increased up to 20 times by the 
incorporation of biopolymers, as demonstrated by recent literature on bioceramic/polymer 
porous composites [74-76]. Furthermore, the scaffold toughness will increase in vivo: for 
instance, porous HA scaffolds, with a brittle response as fabricated, showed an elastoplastic 
response in compression after implantation for 8 weeks in pigs [77]. In general, upon 
implantation of a bioactive/resorbable glass scaffold in a bone defect, the strength of the 
scaffold decreases with time due to conversion of the glass to an HA-like material and/or its 
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progressive degradation, but this should be countered by an increase in strength due to bone 
in-growth [78].  
 
In vitro behaviour. The weight losses of ICEL2 scaffolds after different time frames of 
immersion in SBF are presented in Fig. 10. After soaking for 4 months the samples lost 
almost 76 wt.%. This value is about 2.5 times higher than the one obtained for glass slices; 
although the glass slices were totally amorphous and thus more prone to dissolution than 
ICEL2 in its glass-ceramic form, the scaffold had a higher surface area exposed to SBF and, 
accordingly, its reactivity was emphasized. During the treatment in SBF the scaffold volume 
underwent a progressive reduction but the sample did not collapse; this characteristic is quite 
important as some porous biomaterials dramatically crumble during dissolution, thereby 
losing their structural function. This observation is consistent with the mechanism of 
congruent erosion during contact with aqueous solutions that characterizes phosphate glass-
based biomaterials. 
Figs. 11a,b show the SEM micrographs of the scaffolds before and after immersion in SBF for 
2 months. After soaking the pores became larger and the wall struts between the pores became 
thinner. Some of the pores walls opened during dissolution, thereby leading to pores widening 
and creation of additional interconnects among them; this suggests that the possible presence 
of closed pores in ICEL2 scaffolds before implantation in vivo will not represent a dramatic 
aspect per se, as they will open during scaffold dissolution. Fig. 11c reports a high-
magnification SEM image of scaffold struts after soaking for 2 months in SBF. The presence 
of a newly formed phase, partially closing the small pores on the surface of scaffold struts, 
can be observed. These CaP agglomerates partially coated the scaffold surface, thereby 
making almost undetectable the peaks corresponding to the elements peculiar of scaffold 
composition (Na, Mg, K, Si) in the EDS pattern (Fig. 11d). Therefore, ICEL2 scaffolds were 
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not only resorbable but also bioactive according to the relevant mechanism described by 
Hench [72]. 
Quantitative assessment of pores distribution before and after the treatment in SBF confirmed 
what suggested by SEM micrographs (Fig. 11): in fact, image analysis evaluations performed 
on several low-magnification SEM images demonstrated that after soaking in SBF the total 
pores amount and total pores area increased of about 31 and 36 %, respectively. Pores number 
and pores area distributions are displayed in Fig. 12, wherein the results are normalized and 
expressed in percentage to make easier the comparison of the values before and after 
immersion in SBF. This analysis clearly shows that, due to congruent dissolution of the 
scaffolds, the amount of both small (< 50 µm) and large pores (> 100 µm) increased; 
therefore, the mean pore diameter (about 15 µm) referred to overall porosity P remained 
unaltered before and after the treatment in SBF. Likewise, also the ratios among the pores 
amount and pores area for each class of pore size exhibited moderate differences between the 
two conditions.   
Adhesion and proliferation of osteoblasts as well as the formation of mineralized tissue 
depends on the extracellular pH regulation [79]. The pH variation of the SBF during the 4-
month time span of soaking of ICEL2 scaffolds was within the range for the normal function 
of bone cells (maximum reached value: pH = 7.55) [79].  
An extensive biological characterization of ICEL2 was carried out elsewhere by the authors 
[44,62] and, accordingly, is not reported in the present work. Very briefly, human marrow 
stromal cells seeded on this biomaterial maintained their metabolic activity and ability to 
proliferate (over a 21-day test period); furthermore, cells differentiation over proliferation 
occurred, thereby suggesting potential osteogenic properties of the scaffolds. 
By looking at the future, investigations in dynamic conditions and/or by using bioreactors (in 
vivo-like environment) would provide key information in view of the final in vivo application 
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of the material. In fact, for degradable scaffolds, like those based on phosphate glasses 
including ICEL2, the rate of flow through the material will affect the degradation rate. More 
specifically, differences in flow rate within a scaffold can cause differential degradation rates, 
and for resorbable glass scaffolds areas with higher flow rates are likely to degrade more 
rapidly than areas of low flow. Fluid will always flow along the route of least resistance; flow 
will occur around the edge of the sample as well as through it, and preference flow channels 
may form as material dissolves under the flow rates required for measurement [71]. During in 
vitro cell culture, the flow of culture medium containing cells during cell seeding is critical to 
developing an evenly populated scaffold. In vivo, it is vital that there are paths for cells to 
migrate, tissue to grow in and waste products to flow out. 
 
Conclusions  
 
In this work, a resorbable phosphate glass (ICEL2) was synthesized and characterized to 
investigate its suitability for bone tissue repair. The glass solubility was investigated during a 
time span of 4 months by using distilled water, SBF and Tris-HCl as testing solutions. ICEL2 
glass showed to be resorbable and underwent a process of congruent dissolution produced by 
a surface erosion mechanism. The dissolution rate was both medium- and time-dependent; 
maximum dissolution occurred in distilled water, wherein the glass lost almost 76 wt.% after 
4 months of immersion, whereas the concomitant formation of a HA-like layer was observed 
on the surface of the samples treated in SBF and Tris-HCl, which demonstrated that the 
material was both bioactive and resorbable.   
ICEL2 glass powder was used to prepare highly porous 3-D glass-ceramic scaffolds by means 
of the PE burning-out method. During the heat treatment, the polymeric phase burnt-out while 
the glass crystallized and sintered, thereby forming a glass-ceramic structure. Scaffolds 
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exhibiting a 3-D network of open and highly interconnected macropores, with a trabecular 
architecture analogous to that of cancellous bone, were obtained. A total pore content of about 
87 vol.%, including both large (100-400 µm) and mid to small macropores (below 50 µm), 
was achieved. The compressive strength of the scaffolds was about 1.5 MPa, that is 
acceptable for bone tissue engineering applications. The scaffolds were highly soluble and 
lost about 76 wt.% after 4 months of soaking in SBF. During immersion, the struts between 
the pores became thinner and sometimes they completely disappeared due to a surface erosion 
mechanism, leading to pores enlargement and opening. The pH of SBF during the time frame 
of analysis varied between 7.30-7.55, i.e. between the optimal limits for bone cells viability, 
which further suggests the suitability of ICEL2 scaffolds for bone tissue engineering 
applications.  
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Figure legends 
 
Figure 1. XRD patterns of (a) ICEL2 glass and (b) ICEL2-derived scaffold after thermal 
treatment at 550 °C/3 h. 
 
Figure 2. Differential scanning calorimetry (DSC) plot of ICEL2 glass. 
 
Figure 3. Shrinkage of ICEL2 glass obtained by hot stage microscopy (HSM). 
 
Figure 4. Digital camera images of ICEL2 glass samples before (right side) and after (left 
side) soaking in different testing media for 4 months: (a) distilled water, (b) Tris-HCl, (c) 
SBF. 
 
Figure 5. Weight losses of ICEL2 glass samples during immersion in three testing media 
(distilled water, Tris-HCl and SBF) for different time frames. 
 
Figure 6. Weight loss per unit surface of ICEL2 glass samples during immersion in distilled 
water: experimental data (continuous line) and fitting linear curve (dashed line). 
 
Figure 7. ICEL2 scaffolds: (a) green body (compact body of pressed glass and PE particles; 
sample diameter 30 mm); (b) ICEL2-derived scaffold as extracted from the furnace (after 
thermal treatment at 550 °C/3 h); (c) ICEL2 scaffold after cutting into a regular cubic shape; 
(d) SEM micrograph of the scaffold (magnification 300×). 
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Figure 8. Capillarity test: (a-f) phases of the test carried out on a ICEL2 scaffold; (g) 
comparison of the samples before (left side) and after (right side) the test; (h) cross-sections of 
the scaffolds before (left side) and after (right side) the test.    
 
Figure 9. Compressive stress-strain curve of ICEL2 scaffolds. 
 
Figure 10. Weight losses of ICEL2 scaffolds during immersion in SBF for different time 
frames. 
 
Figure 11. Low-magnification SEM micrographs of ICEL2 scaffolds (a) before and (b) after 
soaking for 2 months in SBF (magnification 50× in both cases); (c) high-magnification 
(1000×) SEM image of scaffold struts showing the presence of a newly formed phases with 
the relevant compositional analysis by EDS (d).  
 
Figure 12. Image analysis: (a) pore size distribution and (b) pores area of ICEL2 scaffold 
before and after soaking for 2 months in SBF. 
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Tables 
 
Table 1. Comparison of thermal parameters among ICEL2 and other biomedical glasses (data available in the literature).  
Material Powder size (µm) δ (°C) KH Sc (°C) References 
ICEL2 < 32 140 1.4 80 Present work 
CEL2 < 32 100 0.28 0 [34] 
45S5 Bioglass® < 32 37 0.066 < 0 [34] 
< 5 (commercial powders) 64 0.25 < 0 [56] 
Glasses in the CaO-MgO-SiO2-P2O5-Na2O-CaF2 system ∼10 - - 74-99 [57] 
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Table 2. Comparison of porosity and mechanical properties of selected bone tissue engineering scaffolds fabricated by PE burning-out and 
sponge replication techniques. 
System and composition (mol.%) of 
the starting glass  
Glass familya Fabrication method Porosity (vol.%) Compressive 
strength (MPa) 
References 
45P2O5-26CaO-15Na2O-3SiO2-4K2O-
7MgO (ICEL2) 
P Sponge replication 85 0.4 [43,44] 
PE burning-out 87 1.5 Present work 
45SiO2-26CaO-15Na2O-3P2O5-4K2O-
7MgO (CEL2) 
S Sponge replication 55-75 b 1.0-5.5 b [33,34,43] 
PE burning-out 48 7 [37] 
50SiO2-18CaO-7Na2O-6P2O5-7K2O-
3MgO-9CaF2 (FaGC) 
S Sponge replication 75 2 [32] 
PE burning-out 23.5-50.0 b 20.0-150.0 b,c [38,39] 
46.1SiO2-26.9CaO-24.4Na2O-2.6P2O5 
(45S5 Bioglass®) 
S Sponge replication 70-90 b 0.4-2.5 b [30,34] 
PE burning-out 60-70 b 117.7-123.2 b [40] 
a
 P = phosphate glass; S = silicate glass. 
b
 Different scaffolds batches were produced by varying the processing parameters in a controlled way (see the related references for details). 
c
 The scaffolds were mechanically anisotropic (different strength were registered if the load was applied along the compaction direction or along 
a transversal direction).  
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